Literature DB >> 8482378

Biochemical and immunological evidence that an acidic domain of hsp 90 is involved in the stabilization of untransformed glucocorticoid receptor complexes.

N Tbarka1, C Richard-Méreau, P Formstecher, M Dautrevaux.   

Abstract

Polyclonal antibodies (AS 232-266) have been raised against the 232-266 amino acid sequence of the mouse hsp 84. This sequence possesses 54% acidic residues. AS 232-266 react with both the denatured and the free native murine hsp 84, but not with the bound hsp 84 present in the untransformed glucocorticoid receptor complexes (GR). Both AS 232-266 and peptide 232-266 were shown to decrease [3H]dexamethasone binding by GR. Moreover synthetic peptide 232-266, when added to 7 nm untransformed GR, convert them into 5 nm hsp 84-free GR. Taken together these data suggest that the acidic 232-266 sequence of hsp 84 is involved in the stabilization of the hsp 84-GR interaction, which is known to result in 7 nm complex formation and in GR ligand binding activity improvement. Both peptide 232-266 and AS 232-266 destabilize this interaction.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8482378     DOI: 10.1016/0014-5793(93)81551-a

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  3 in total

1.  Two eukaryote-specific regions of Hsp82 are dispensable for its viability and signal transduction functions in yeast.

Authors:  J F Louvion; R Warth; D Picard
Journal:  Proc Natl Acad Sci U S A       Date:  1996-11-26       Impact factor: 11.205

2.  A truncated form of p23 down-regulates telomerase activity via disruption of Hsp90 function.

Authors:  Sang Hyeok Woo; Sungkwan An; Hyung-Chahn Lee; Hyeon-Ok Jin; Sung-Keum Seo; Doo-Hyun Yoo; Kee-Ho Lee; Chang Hun Rhee; Eui-Ju Choi; Seok-Il Hong; In-Chul Park
Journal:  J Biol Chem       Date:  2009-09-09       Impact factor: 5.157

3.  Combined pharmacological induction of Hsp70 suppresses prion protein neurotoxicity in Drosophila.

Authors:  Yan Zhang; Sergio Casas-Tinto; Diego E Rincon-Limas; Pedro Fernandez-Funez
Journal:  PLoS One       Date:  2014-02-11       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.